BLGO — BioLargo, Inc. Dilution Risk Tracker

BioLargo, Inc. (BLGO) has a DilutionScore of 42/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

The most significant dilution vector for BLGO is its shelf registration capacity of $10.0M. A shelf registration (typically an S-3 filing) gives a company pre-approved access to raise capital quickly without a traditional roadshow. The registered amount represents the maximum that can be raised — not necessarily what will be raised — but active shelves combined with tight cash positions are the pattern DilutionWatch monitors most closely. DilutionWatch tracks 4.3M outstanding warrants for BLGO. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for BLGO in real-time, scanning EDGAR every 60 seconds. A recent S-3 or registration statement filing appears in BLGO's filing history — this warrants monitoring for subsequent prospectus supplements (Form 424B), which indicate active capital raising. The DilutionWatch screener shows real-time score changes for BLGO alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.